Champions Oncology Inc
NASDAQ:CSBR
Champions Oncology Inc
Revenue
Champions Oncology Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Champions Oncology Inc
NASDAQ:CSBR
|
Revenue
$49.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Champions Oncology Inc
Revenue Breakdown
Breakdown by Geography
Champions Oncology Inc
Breakdown by Segments
Champions Oncology Inc
Total Revenue:
53.9m
USD
|
Pharmacology Services:
50.7m
USD
|
Other Services:
3m
USD
|
Personalized Oncology Services:
116k
USD
|
See Also
What is Champions Oncology Inc's Revenue?
Revenue
49.2m
USD
Based on the financial report for Jan 31, 2024, Champions Oncology Inc's Revenue amounts to 49.2m USD.
What is Champions Oncology Inc's Revenue growth rate?
Revenue CAGR 10Y
16%
Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Champions Oncology Inc have been 8% over the past three years , 15% over the past five years , and 16% over the past ten years .